CULLINAN THERAPEUTICS Trademark
Trademark Overview
On Monday, August 26, 2024, a trademark application was filed for CULLINAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CULLINAN THERAPEUTICS trademark a serial number of 98717377. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 10, 2025. This trademark is owned by Cullinan Therapeutics, Inc.. The CULLINAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology; pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology
General Information
| Serial Number | 98717377 |
| Word Mark | CULLINAN THERAPEUTICS |
| Filing Date | Monday, August 26, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, March 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the literal elements CULLINAN THERAPEUTICS with a stylized wing appearing over the "I" in CULLINAN. |
| Goods and Services | Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology; pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, May 31, 2024 |
| First Use In Commerce Date | Friday, May 31, 2024 |
Trademark Owner History
| Party Name | Cullinan Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Monday, August 26, 2024 | NEW APPLICATION ENTERED |
| Wednesday, February 26, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, February 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 3, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 10, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, March 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 10, 2025 | NON-FINAL ACTION WRITTEN |
